Beta-adrenergic blocking drugs in anxiety and stress.
A series of controlled studies have demonstrated an antianxiety effect of beta-adrenergic blocking drugs in patients with anxiety. Also, in certain performance situations, beta-blocking drugs may block the autonomic response to stress and reduce anxiety. However, because these drugs are less effective than the benzodiazepines, their role in the treatment of anxiety and phobic disorders appears to be limited.
Noyes
R
R
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy / Q000523:psychology; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D001249:Asthma / Q000139:chemically induced; D001569:Benzodiazepines; D002986:Clinical Trials as Topic; D003693:Delirium / Q000139:chemically induced; D003866:Depressive Disorder / Q000139:chemically induced; D004357:Drug Synergism; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D010096:Oxprenolol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010698:Phobic Disorders / Q000188:drug therapy / Q000523:psychology; D011433:Propranolol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013315:Stress, Psychological / Q000188:drug therapy* / Q000523:psychology; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy / Q000523:psychology; D019966:Substance-Related Disorders / Q000188:drug therapy / Q000523:psychology
D000319:Adrenergic beta-Antagonists; D014151:Anti-Anxiety Agents; D008996:Monoamine Oxidase Inhibitors; D001569:Benzodiazepines; D010096:Oxprenolol; D011433:Propranolol